We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+34.63%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$208M
AUM Growth
-$246M
Cap. Flow
-$176M
Cap. Flow %
-84.46%
Top 10 Hldgs %
83.47%
Holding
151
New
27
Increased
12
Reduced
37
Closed
67

Top Buys

Rank Stock Value
1
HMTV
Hemisphere Media Group, Inc.
HMTV
+$9.46M
2
LOOP icon
Loop Industries
LOOP
+$2.38M
3
TRNX
Taronis Technologies, Inc. Common Stock
TRNX
+$1.52M
4
NVAX icon
Novavax
NVAX
+$1.36M
5
CODX
Co-Diagnostics
CODX
+$928K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$37.5M
2
ESPR
Esperion Therapeutics
ESPR
+$6.39M
3
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$4.97M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$4.47M
5
XERS icon
Xeris Biopharma Holdings
XERS
+$3.45M

Sector Composition

Rank Sector Weight
1 Healthcare 10.57%
2 Materials 0.95%
3 Consumer Discretionary 0.9%
4 Technology 0.61%
5 Industrials 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LFWD icon
51
ReWalk Robotics
LFWD
$19.6M
$198K 0.1%
436
-1,120
-72% -$591K
USIO icon
52
Usio Inc
USIO
$53.8M
$193K 0.09%
+73,773
New +$199K
TTNP
53
PUT
DELISTED
Titan Pharmaceuticals
TTNP
$184K 0.09%
+2
New +$1.94K
CRMD icon
54
CorMedix
CRMD
$577M
$171K 0.08%
18,118
+11,986
+195% +$108K
AKAO
55
DELISTED
Achaogen Inc
AKAO
$159K 0.08%
+348,400
New +$366K
KPTI icon
56
Karyopharm Therapeutics
KPTI
$161M
$146K 0.07%
+1,667
New +$185K
HMTV
57
DELISTED
Hemisphere Media Group, Inc.
HMTV
$113K 0.05%
+708,417
New +$9.46M
CVM.WS
58
PUT
DELISTED
Cel-Sci Corp Series S
CVM.WS
$110K 0.05%
312
+202
+184% +$71.2K
PALI icon
59
Palisade Bio
PALI
$351M
$106K 0.05%
3
-14
-82% -$572K
NOVN
60
DELISTED
Novan, Inc. Common Stock
NOVN
$82K 0.04%
8,623
-12,683
-60% -$160K
NXTP
61
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$73K 0.04%
1,799
-23,722
-93% -$1.08M
FCEL icon
62
FuelCell Energy
FCEL
$1.57B
$59K 0.03%
671
+568
+551% +$98K
SGLBW
63
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
$57K 0.03%
88,467
-100,346
-53% -$68.8K
KA
64
DELISTED
Kineta, Inc. Common Stock
KA
$39K 0.02%
+221
New +$108K
ONTXW
65
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$35K 0.02%
641,362
-19,608
-3% -$2.49K
SPHS
66
DELISTED
Sophiris Bio, Inc.
SPHS
$33K 0.02%
33,643
+21,597
+179% +$23.2K
BNBX
67
PUT
DELISTED
BNB PLUS CORP
BNBX
– –
0
– –
KA
68
CALL
DELISTED
Kineta, Inc. Common Stock
KA
$28K 0.01%
+2
New +$979
PLUR icon
69
PUT
Pluri
PLUR
$18.1M
$23K 0.01%
3
-1
-25% -$83
IMNN icon
70
CALL
Imunon
IMNN
$6.43M
$20K 0.01%
+1
New +$415
BLIN icon
71
Bridgeline Digital
BLIN
$14.9M
$16K 0.01%
2,000
-13,580
-87% -$164K
BLRX
72
BioLineRX
BLRX
$12.2M
$16K 0.01%
+62
New +$18.1K
FCEL icon
73
PUT
FuelCell Energy
FCEL
$1.57B
$11K 0.01%
1
-1
-50% -$173
NVAX icon
74
CALL
Novavax
NVAX
$1.21B
$8K ﹤0.01%
+8
New +$253
BNTCW
75
DELISTED
Benitec Biopharma Limited
BNTCW
$6K ﹤0.01%
57,949
-101
-0.2% -$15
1 2
3
4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2019 Portfolio in Review

As of Q1 2019, Sabby Management held 151 positions worth $208M, down 54% from $455M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Sabby Management withdrew a net $176M in Q1 2019, closing 67 positions and reducing 37 holdings. Its most notable exit was Esperion Therapeutics, an estimated $6.39M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 21% a quarter earlier, followed by Materials and Consumer Discretionary.

Against the trend, Sabby Management opened a new position in Hemisphere Media Group, Inc. worth $113K.

  • Sabby Management's largest Q1 2019 buy was Hemisphere Media Group, Inc.: 708,417 shares worth $113K.
  • Sabby Management added most to OpGen, Inc in Q1 2019, an estimated $921K increase.
  • Sabby Management's biggest Q1 2019 reduction was Biogen, cutting an estimated $37.5M.
  • Sabby Management fully exited Esperion Therapeutics in Q1 2019, selling an estimated $6.39M.
  • Sabby Management's ten largest holdings make up 83% of its $208M portfolio in Q1 2019.
  • Sabby Management opened 27 new positions and closed 67 in Q1 2019.
  • Sabby Management's portfolio value fell 54% quarter-over-quarter to $208M.

Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.